The <scp>BCL</scp>2 antagonist <scp>ABT</scp>‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in <i><scp>CXCR</scp>4</i>^{<i>Wild‐type</i>} and <i><scp>CXCR</scp>4</i><scp>^<i>WHIM</i></scp> mutated Waldenstrom macroglobulinaemia cells

Yang Cao, Steven P. Treon, Jorge J. Castillo et al.|British Journal of Haematology|2015

Cited by 71